These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

80 related items for PubMed ID: 14973505

  • 1. Defective class II transactivator expression in a B lymphoma cell line.
    Prod'homme T, Drénou B, De Ruyffelaere C, Barbieri G, Wiszniewski W, Bastard C, Charron D, Alcaide-Loridan C.
    Leukemia; 2004 Apr; 18(4):832-40. PubMed ID: 14973505
    [Abstract] [Full Text] [Related]

  • 2. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome).
    Steimle V, Otten LA, Zufferey M, Mach B.
    Cell; 1993 Oct 08; 75(1):135-46. PubMed ID: 8402893
    [Abstract] [Full Text] [Related]

  • 3. Alterations in CIITA constitute a common mechanism accounting for downregulation of MHC class II expression in diffuse large B-cell lymphoma (DLBCL).
    Cycon KA, Rimsza LM, Murphy SP.
    Exp Hematol; 2009 Feb 08; 37(2):184-194. PubMed ID: 19081173
    [Abstract] [Full Text] [Related]

  • 4. Active suppression of the class II transactivator-encoding AIR-1 locus is responsible for the lack of major histocompatibility complex class II gene expression observed during differentiation from B cells to plasma cells.
    Sartoris S, Tosi G, De Lerma Barbaro A, Cestari T, Accolla RS.
    Eur J Immunol; 1996 Oct 08; 26(10):2456-60. PubMed ID: 8898960
    [Abstract] [Full Text] [Related]

  • 5. Epigenetic inactivation of class II transactivator (CIITA) is associated with the absence of interferon-gamma-induced HLA-DR expression in colorectal and gastric cancer cells.
    Satoh A, Toyota M, Ikeda H, Morimoto Y, Akino K, Mita H, Suzuki H, Sasaki Y, Kanaseki T, Takamura Y, Soejima H, Urano T, Yanagihara K, Endo T, Hinoda Y, Fujita M, Hosokawa M, Sato N, Tokino T, Imai K.
    Oncogene; 2004 Nov 25; 23(55):8876-86. PubMed ID: 15467734
    [Abstract] [Full Text] [Related]

  • 6. CIITA-dependent and -independent class II MHC expression revealed by a dominant negative mutant.
    Zhou H, Su HS, Zhang X, Douhan J, Glimcher LH.
    J Immunol; 1997 May 15; 158(10):4741-9. PubMed ID: 9144488
    [Abstract] [Full Text] [Related]

  • 7. Detection of aberrant transcription of major histocompatibility complex class II antigen presentation genes in chronic lymphocytic leukaemia identifies HLA-DOA mRNA as a prognostic factor for survival.
    Souwer Y, Chamuleau ME, van de Loosdrecht AA, Tolosa E, Jorritsma T, Muris JJ, Dinnissen-van Poppel MJ, Snel SN, van de Corput L, Ossenkoppele GJ, Meijer CJ, Neefjes JJ, Marieke van Ham S.
    Br J Haematol; 2009 May 15; 145(3):334-43. PubMed ID: 19245431
    [Abstract] [Full Text] [Related]

  • 8. Two newly diagnosed HLA class II-deficient patients identified by rapid vector-based complementation analysis reveal discoordinate invariant chain expression levels.
    Schmetterer KG, Seidel MG, Körmöczi U, Rottal A, Schwarz K, Matthes-Martin S, Steinberger P, Pickl WF.
    Int Arch Allergy Immunol; 2010 May 15; 152(4):390-400. PubMed ID: 20197681
    [Abstract] [Full Text] [Related]

  • 9. HLA class II expression in uninducible hepatocarcinoma cells after transfection of AIR-1 gene product CIITA: acquisition of antigen processing and presentation capacity.
    Sartoris S, Valle MT, Barbaro AL, Tosi G, Cestari T, D'Agostino A, Megiovanni AM, Manca F, Accolla RS.
    J Immunol; 1998 Jul 15; 161(2):814-20. PubMed ID: 9670958
    [Abstract] [Full Text] [Related]

  • 10. Regulation of MHC class II expression in glioma cells by class II transactivator (CIITA).
    Takamura Y, Ikeda H, Kanaseki T, Toyota M, Tokino T, Imai K, Houkin K, Sato N.
    Glia; 2004 Mar 15; 45(4):392-405. PubMed ID: 14966870
    [Abstract] [Full Text] [Related]

  • 11. Single nucleotide polymorphisms in MHC2TA, the gene encoding the MHC class II transactivator (CIITA).
    Patarroyo JC, Stuve O, Piskurich JF, Hauser SL, Oksenberg JR, Zamvil SS.
    Genes Immun; 2002 Feb 15; 3(1):34-7. PubMed ID: 11857059
    [Abstract] [Full Text] [Related]

  • 12. Epigenetic silencing of the CIITA gene and posttranscriptional regulation of class II MHC genes in ocular melanoma cells.
    Radosevich M, Song Z, Gorga JC, Ksander B, Ono SJ.
    Invest Ophthalmol Vis Sci; 2004 Sep 15; 45(9):3185-95. PubMed ID: 15326139
    [Abstract] [Full Text] [Related]

  • 13. CIITA versus IFN-gamma induced MHC class II expression in head and neck cancer cells.
    Meissner M, Whiteside TL, Kaufmann R, Seliger B.
    Arch Dermatol Res; 2009 Feb 15; 301(2):189-93. PubMed ID: 19104823
    [Abstract] [Full Text] [Related]

  • 14. IL-1 beta inhibits IFN-gamma-induced class II MHC expression by suppressing transcription of the class II transactivator gene.
    Rohn W, Tang LP, Dong Y, Benveniste EN.
    J Immunol; 1999 Jan 15; 162(2):886-96. PubMed ID: 9916712
    [Abstract] [Full Text] [Related]

  • 15. Epigenetic silencing of MHC2TA transcription in cancer.
    Holling TM, van Eggermond MC, Jager MJ, van den Elsen PJ.
    Biochem Pharmacol; 2006 Nov 30; 72(11):1570-6. PubMed ID: 16879803
    [Abstract] [Full Text] [Related]

  • 16. Correction of defective expression in MHC class II deficiency (bare lymphocyte syndrome) cells by retroviral transduction of CIITA.
    Bradley MB, Fernandez JM, Ungers G, Diaz-Barrientos T, Steimle V, Mach B, O'Reilly R, Lee JS.
    J Immunol; 1997 Aug 01; 159(3):1086-95. PubMed ID: 9233601
    [Abstract] [Full Text] [Related]

  • 17. Induction of CIITA and modification of in vivo HLA-DR promoter occupancy in normal thymic epithelial cells treated with IFN-gamma: similarities and distinctions with respect to HLA-DR-constitutive B cells.
    Rigaud G, De Lerma Barbaro A, Nicolis M, Cestari T, Ramarli D, Riviera AP, Accolla RS.
    J Immunol; 1996 Jun 01; 156(11):4254-8. PubMed ID: 8666795
    [Abstract] [Full Text] [Related]

  • 18. Conserved residues of the bare lymphocyte syndrome transcription factor RFXAP determine coordinate MHC class II expression.
    Long AB, Ferguson AM, Majumder P, Nagarajan UM, Boss JM.
    Mol Immunol; 2006 Feb 01; 43(5):395-409. PubMed ID: 16337482
    [Abstract] [Full Text] [Related]

  • 19. Prolonged MHC class II expression and CIITA transcription in human keratinocytes.
    Takagi A, Nishiyama C, Kanada S, Niwa Y, Fukuyama K, Ikeda S, Okumura K, Ogawa H.
    Biochem Biophys Res Commun; 2006 Aug 25; 347(2):388-93. PubMed ID: 16836979
    [Abstract] [Full Text] [Related]

  • 20. Down-regulation of MHC class II expression through inhibition of CIITA transcription by lytic transactivator Zta during Epstein-Barr virus reactivation.
    Li D, Qian L, Chen C, Shi M, Yu M, Hu M, Song L, Shen B, Guo N.
    J Immunol; 2009 Feb 15; 182(4):1799-809. PubMed ID: 19201831
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.